JP2021516271A5 - - Google Patents
Info
- Publication number
- JP2021516271A5 JP2021516271A5 JP2020544672A JP2020544672A JP2021516271A5 JP 2021516271 A5 JP2021516271 A5 JP 2021516271A5 JP 2020544672 A JP2020544672 A JP 2020544672A JP 2020544672 A JP2020544672 A JP 2020544672A JP 2021516271 A5 JP2021516271 A5 JP 2021516271A5
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- alginate
- compound
- alkyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024010323A JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637803P | 2018-03-02 | 2018-03-02 | |
| US62/637,803 | 2018-03-02 | ||
| US201862652883P | 2018-04-04 | 2018-04-04 | |
| US62/652,883 | 2018-04-04 | ||
| PCT/US2019/020405 WO2019169333A1 (en) | 2018-03-02 | 2019-03-01 | Afibrotic compounds, devices, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024010323A Division JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516271A JP2021516271A (ja) | 2021-07-01 |
| JP2021516271A5 true JP2021516271A5 (enExample) | 2022-03-10 |
Family
ID=65812415
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544672A Pending JP2021516271A (ja) | 2018-03-02 | 2019-03-01 | 抗線維化化合物、デバイス、及びその使用 |
| JP2024010323A Pending JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024010323A Pending JP2024052741A (ja) | 2018-03-02 | 2024-01-26 | 抗線維化化合物、デバイス、及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12605486B2 (enExample) |
| EP (1) | EP3759101A1 (enExample) |
| JP (2) | JP2021516271A (enExample) |
| KR (1) | KR20210004969A (enExample) |
| CN (1) | CN112105612A (enExample) |
| AU (2) | AU2019226587A1 (enExample) |
| CA (1) | CA3092121A1 (enExample) |
| IL (1) | IL276753B1 (enExample) |
| TW (1) | TW201938592A (enExample) |
| WO (1) | WO2019169333A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY38389A (es) * | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | Dispositivos implantables para terapia celular y métodos relacionados |
| WO2021062273A1 (en) * | 2019-09-27 | 2021-04-01 | Sigilon Therapeutics, Inc. | Methods of evaluating small molecule-modified polymers in compositions |
| CN117940504A (zh) * | 2021-06-14 | 2024-04-26 | 威廉马什莱斯大学 | 含有三唑的聚合物及其使用方法 |
| WO2023230524A1 (en) | 2022-05-25 | 2023-11-30 | Flagship Pioneering Innovations Vi, Llc | Compositions of secretory and/or catalytic cells and methods using the same |
| WO2023235884A1 (en) | 2022-06-03 | 2023-12-07 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods |
| CN119546647A (zh) | 2022-07-01 | 2025-02-28 | 西吉隆医疗股份有限公司 | 共价光交联多糖及其使用方法 |
| CN116023525B (zh) * | 2023-02-13 | 2024-03-15 | 湖北工程学院 | 一种2-位(1,4-二取代-1,2,3-三唑)修饰的壳聚糖衍生物及其制备方法和应用 |
| WO2024191428A1 (en) | 2023-03-14 | 2024-09-19 | Sigilon Therapeutics, Inc. | Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells |
| WO2026026917A1 (zh) * | 2024-07-31 | 2026-02-05 | 北京拓界生物医药科技有限公司 | 一种修饰的聚合物及其用途 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| AU2798599A (en) | 1998-02-27 | 1999-09-15 | Bioelastics Research Ltd. | Injectable implants for tissue augmentation and restoration |
| US20090148906A1 (en) | 1998-09-29 | 2009-06-11 | Shire Human Genetic Therapies, Inc. A Delaware Corporation | Optimized messenger rna |
| US6361771B1 (en) | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
| CA2445568A1 (en) | 2001-04-27 | 2002-11-07 | Vertex Pharmaceuticals Incorporated | Triazole-derived kinase inhibitors and uses thereof |
| WO2004064971A2 (en) | 2003-01-23 | 2004-08-05 | Inotech Ag | Process for preparing microcapsules having an improved mechanical resistance |
| PE20080906A1 (es) | 2006-08-17 | 2008-07-05 | Kemia Inc | Derivados heteroarilo como inhibidores de citocina |
| US20080242694A1 (en) | 2006-09-18 | 2008-10-02 | D Sidocky Neil R | Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| WO2010005533A2 (en) | 2008-06-30 | 2010-01-14 | The Johns Hopkins University | Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| AU2010206374B2 (en) | 2009-01-23 | 2013-01-17 | Gloriana Therapeutics Sarl | Improved cell lines and their use in encapsulated cell biodelivery |
| JP5725475B2 (ja) | 2010-01-21 | 2015-05-27 | 公立大学法人名古屋市立大学 | ヒドロキサム酸誘導体及びそれを用いたｈｄａｃ８阻害剤 |
| US9867781B2 (en) | 2011-02-18 | 2018-01-16 | Massachusetts Institute Of Technology | Hydrogel encapsulated cells and anti-inflammatory drugs |
| DK3354665T5 (da) | 2011-06-02 | 2022-09-19 | Massachusetts Inst Technology | Modificerede alginater til celleindkapsling og celleterapi |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| US9555007B2 (en) | 2013-03-14 | 2017-01-31 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| ES2845473T3 (es) | 2013-03-14 | 2021-07-26 | Boehringer Ingelheim Int | (Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C |
| US10172791B2 (en) | 2013-03-14 | 2019-01-08 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| GB201304973D0 (en) | 2013-03-19 | 2013-05-01 | Profactor Pharma Ltd | Recombinant protein |
| ITTO20130356A1 (it) | 2013-05-03 | 2014-11-04 | Uni Degli Studi Del Piemonte Orientale Ame | Inibitori di nicotinamide fosforibosil transferasi, relative composizioni, prodotti ed usi |
| WO2014182684A2 (en) | 2013-05-06 | 2014-11-13 | Cell Machines, Inc. | Methods and compositions related to large scale production of proteins |
| CA2922483A1 (en) | 2013-09-11 | 2015-03-19 | Neurotech Usa, Inc. | Encapsulated cell therapy cartridge |
| PL3628334T3 (pl) | 2014-03-21 | 2023-12-18 | Genzyme Corporation | Terapia genowa w retinopatii barwnikowej |
| CN104072478B (zh) | 2014-05-22 | 2016-06-01 | 大连理工大学 | 一类萘环4位含1,2,3-三唑的萘酰亚胺衍生物的合成及其应用 |
| US11008561B2 (en) | 2014-06-30 | 2021-05-18 | Bioverativ Therapeutics Inc. | Optimized factor IX gene |
| KR102719485B1 (ko) | 2014-08-01 | 2024-10-21 | 메사추세츠 인스티튜트 오브 테크놀로지 | 항-섬유 물질 및 응용을 위한 변형된 알기네이트 |
| EP3297693A1 (en) | 2015-05-17 | 2018-03-28 | Massachusetts Institute of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
| JPWO2017018086A1 (ja) | 2015-07-29 | 2018-02-01 | Ｎｉｓｓｈａ株式会社 | マイクロニードルシート |
| IL242380A0 (en) | 2015-10-29 | 2016-02-01 | Yeda Res & Dev | A method of inducing cardiomyocytes proliferation and treating heart diseases |
| AU2016344041B2 (en) | 2015-11-01 | 2019-11-07 | Massachusetts Institute Of Technology | Materials with improved properties |
| NZ742800A (en) * | 2015-11-01 | 2019-03-29 | Massachusetts Inst Technology | Modified alginates for anti-fibrotic materials and applications |
| CA3012695A1 (en) | 2016-02-01 | 2017-08-10 | Bioverativ Therapeutics Inc. | Optimized factor viii genes |
| WO2017201328A1 (en) | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE |
| KR20190092374A (ko) * | 2016-10-03 | 2019-08-07 | 시질론 테라퓨틱스, 인크. | 화합물, 장치, 및 이의 용도 |
| WO2018206168A1 (en) | 2017-05-11 | 2018-11-15 | Zentrum Für Forschungsförderung In Der Pädiatrie Gmbh | Concept for the treatment of monogenetic disorders |
| EP3687580A1 (en) | 2017-09-27 | 2020-08-05 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising active cells |
| US20210145889A1 (en) | 2018-04-04 | 2021-05-20 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising stem cells |
-
2019
- 2019-03-01 US US16/977,724 patent/US12605486B2/en active Active
- 2019-03-01 CN CN201980016665.2A patent/CN112105612A/zh active Pending
- 2019-03-01 AU AU2019226587A patent/AU2019226587A1/en not_active Abandoned
- 2019-03-01 WO PCT/US2019/020405 patent/WO2019169333A1/en not_active Ceased
- 2019-03-01 CA CA3092121A patent/CA3092121A1/en active Pending
- 2019-03-01 JP JP2020544672A patent/JP2021516271A/ja active Pending
- 2019-03-01 KR KR1020207028383A patent/KR20210004969A/ko not_active Ceased
- 2019-03-01 EP EP19711765.8A patent/EP3759101A1/en active Pending
- 2019-03-04 TW TW108107146A patent/TW201938592A/zh unknown
-
2020
- 2020-08-17 IL IL276753A patent/IL276753B1/en unknown
-
2024
- 2024-01-26 JP JP2024010323A patent/JP2024052741A/ja active Pending
- 2024-07-11 AU AU2024204785A patent/AU2024204785A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516271A5 (enExample) | ||
| JP2019529579A5 (enExample) | ||
| RU2012110007A (ru) | Имидазохинолины в качестве двойных ингибиторов липидкиназы и mtor | |
| JP2017528444A5 (enExample) | ||
| JP2022506111A5 (enExample) | ||
| PH12021551116A1 (en) | Functionalized heterocycles as antiviral agents | |
| JP2018188440A5 (enExample) | ||
| JP2022095872A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2017526726A5 (enExample) | ||
| JP2008195730A5 (enExample) | ||
| RU2016106152A (ru) | Композиция, содержащая гиалуроновую кислоту и мепивакаин | |
| JP2021515083A5 (enExample) | ||
| JP2018519343A5 (enExample) | ||
| JP2017524025A5 (enExample) | ||
| JP2008509928A5 (enExample) | ||
| JP2013520986A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| JP2022526408A5 (enExample) | ||
| JP2020527382A (ja) | Ｎ−オキシド及びエクトインモノマー、ポリマー、それらの組成物及び関連方法 | |
| JP2021516271A (ja) | 抗線維化化合物、デバイス、及びその使用 | |
| NZ610732A (en) | Novel angiotensin type 2 (at2) receptor agonists and uses thereof | |
| JP2010500962A5 (enExample) | ||
| JP2019513868A5 (enExample) | ||
| JP2019500380A5 (enExample) |